Adeno-associated virus serotypes: Vector toolkit for human gene therapy

被引:668
作者
Wu, Zhijian [1 ]
Asokan, Aravind [1 ]
Samulski, R. Jude [1 ]
机构
[1] Univ N Carolina, Sch Med, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
关键词
adeno-associated virus; serotype; tropism; vector; hybrid;
D O I
10.1016/j.ymthe.2006.05.009
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recombinant adeno-associated viral (AAV) vectors have rapidly advanced to the forefront of gene therapy in the past decade. The exponential progress of AAV-based vectors has been made possible by the isolation of several naturally occurring AAV serotypes and over 100 AAV variants from different animal species. These isolates are ideally suited to development into human gene therapy vectors due to their diverse tissue tropisms and potential to evade preexisting neutralizing antibodies against the common human AAV serotype 2. Despite their prolific application in several animal models of disease, the mechanisms underlying selective tropisms of AAV serotypes remain largely unknown. Efforts to understand cell surface receptor usage and intracellular trafficking pathways exploited by AAV continue to provide significant insight into the biology of AAV vectors. Such unique traits are thought to arise from differences in surface topology of the capsids of AAV serotypes and variants. In addition to the aforementioned naturally evolved AAV isolates, several strategies to engineer hybrid AAV serotype vectors have been formulated in recent years. The generation of mosaic or chimeric vectors through the transcapsiclation or marker-rescue/domain-swapping approach, respectively, is notable in this regard. More recently, combinatorial strategies for engineering AAV vectors using error-prone PCR, DNA shuffling, and other molecular cloning techniques have been established. The latter library-based approaches can serve as powerful tools in the generation of low-immunogenic and cell/tissue type-specific AAV vectors for gene delivery. This review is focused on recent developments in the isolation of novel AAV serotypes and isolates, their production and purification, diverse tissue tropisms, mechanisms of cellular entry/trafficking, and capsid structure. Strategies for engineering hybrid AAV vectors derived from AAV serotypes and potential implications of the rapidly expanding AAV vector toolkit are discussed.
引用
收藏
页码:316 / 327
页数:12
相关论文
共 129 条
[61]  
Hanssen R.F., 2001, RE S D I PR, V2, DOI 10.1007/0-306-47633-9
[62]   Characterization of tissue tropism determinants of adeno-associated virus type 1 [J].
Hauck, B ;
Xiao, WD .
JOURNAL OF VIROLOGY, 2003, 77 (04) :2768-2774
[63]   Generation and characterization of chimeric recombinant AAV vectors [J].
Hauck, B ;
Chen, L ;
Xiao, WD .
MOLECULAR THERAPY, 2003, 7 (03) :419-425
[64]   STUDIES OF SMALL DNA VIRUSES FOUND IN VARIOUS ADENOVIRUS PREPARATIONS - PHYSICAL BIOLOGICAL AND IMMUNOLOGICAL CHARACTERISTICS [J].
HOGGAN, MD ;
BLACKLOW, NR ;
ROWE, WP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1966, 55 (06) :1467-&
[65]   Coinfection of a bearded dragon, Pogona vitticeps, with adenovirus- and dependovirus-like viruses [J].
Jacobson, ER ;
Kopit, W ;
Kennedy, FA ;
Funk, RS .
VETERINARY PATHOLOGY, 1996, 33 (03) :343-346
[66]   Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography [J].
Kaludov, N ;
Handelman, B ;
Chiorini, JA .
HUMAN GENE THERAPY, 2002, 13 (10) :1235-1243
[67]   Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity [J].
Kaludov, N ;
Brown, KE ;
Walters, RW ;
Zabner, J ;
Chiorini, JA .
JOURNAL OF VIROLOGY, 2001, 75 (15) :6884-6893
[68]   Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection [J].
Kashiwakura, Y ;
Tamayose, K ;
Iwabuchi, K ;
Hirai, Y ;
Shimada, T ;
Matsumoto, K ;
Nakamura, T ;
Watanabe, M ;
Oshimi, K ;
Daida, H .
JOURNAL OF VIROLOGY, 2005, 79 (01) :609-614
[69]   Identification of a heparin-binding motif on adeno-associated virus type 2 capsids [J].
Kern, A ;
Schmidt, K ;
Leder, C ;
Müller, OJ ;
Wobus, CE ;
Bettinger, K ;
Von der Lieth, CW ;
King, JA ;
Kleinschmidt, JA .
JOURNAL OF VIROLOGY, 2003, 77 (20) :11072-11081
[70]   Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system [J].
Kohlbrenner, E ;
Aslanidi, G ;
Nash, K ;
Shklyaev, S ;
Campbell-Thompson, M ;
Byrne, BJ ;
Snyder, RO ;
Muzyczka, N ;
Warrington, KH ;
Zolotukhin, S .
MOLECULAR THERAPY, 2005, 12 (06) :1217-1225